What is GH's current stock price?

As of now, GH is trading at $101.74, with a daily change of -0.39%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

GH Stock Analysis & IQ Rating | Guardant Health

GH

Guardant Health

$101.74

-$0.40 | -0.39%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$111.91

MKT CAP

$13.11B

52W Low

$31.75

VOL

$828.33K

P/E Ratio

N/A

AVG VOL

$2.09M

RSI

53.66

TREND

Uptrend

BQ Stock IQ

Login to see Guardant Health (GH) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

GH Target Price

Login to display

Strengths

GH Rewards

Upgraded on attractively valued

GH Rewards

Earnings are forecast to grow

GH Rewards

Outperform the market

GH Price Performance

$108.52 (-6.25%)

$63.44 (+60.37%)

$54.8 (+85.66%)

$36.66 (+177.52%)

1year

6month

3month

1month

GH Risk Level

GH has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Fair

LOW

HIGH

GH Analysts Opinion

GH overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

GH Analysts Opinion

GH Analysts opinion is positive and also has improved from the past 3 months

GH Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

81%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

43%

100%

GH Street Sentiment

GH Street Sentiment is extremely bullish and have positive views on the near-term outlook

GH Performance Sentiment

Sentiments overview associated with GH events and the stock performance.

81%

19%

Positive

Negative

17 out of 21
events present

4 out of 21
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$102.14

Resistance
Price

$100.30

Current Price Range

$108.52

Show methods +

Linked to GH

IQ

Close Price

Change

LH

2.54

251.43

+0.33%

EXAS

4.00

101.74

+0.18%

GH Latest Analysis +

Canaccord Names Guardant Health (GH) Top Life Science Pick Cites Strong Growth and Low Downside. Guardant Health Inc. (NASDAQ:GH) is one of the hottest large-cap stocks of 2025. On December 22 Canaccord raised the firms price target on Guardant Health to $125 from $100 with a Buy rating on the shares. The firm expects the life science sector to maintain its current upward trend well into 2026. Guardant Health remains [….]

Wed Dec 31, 2025

$102.14 | +1.53%

Momentum

Potential

Canaccord Genuity Maintains Guardant Health (GH) Buy Recommendation. Fintel reports that on December 22 2025 Canaccord Genuity maintained coverage of Guardant Health (NasdaqGS:GH) with a Buy recommendation. Analyst Price Forecast Suggests 7.76% Upside

Tue Dec 23, 2025

$102.50 | +1.14%

Rating

Mizuho Maintains Guardant Health (GH) Outperform Recommendation. Fintel reports that on December 17 2025 Mizuho maintained coverage of Guardant Health (NasdaqGS:GH) with a Outperform recommendation. Analyst Price Forecast Suggests 3.51% Upside

Thu Dec 18, 2025

$97.10 | -0.38%

Potential

Rating

Leerink Partners Maintains Guardant Health (GH) Outperform Recommendation. Fintel reports that on December 15 2025 Leerink Partners maintained coverage of Guardant Health (NasdaqGS:GH) with a Outperform recommendation. Analyst Price Forecast Suggests 1.90% Downside

Tue Dec 16, 2025

$100.00 | -2.60%

Momentum

Potential

Rating

Barclays Maintains Guardant Health (GH) Overweight Recommendation. Fintel reports that on December 15 2025 Barclays maintained coverage of Guardant Health (NasdaqGS:GH) with a Overweight recommendation. Analyst Price Forecast Suggests 1.90% Downside

Tue Dec 16, 2025

$100.00 | -2.60%

Momentum

Rating

JP Morgan Maintains Guardant Health (GH) Overweight Recommendation. Fintel reports that on December 15 2025 JP Morgan maintained coverage of Guardant Health (NasdaqGS:GH) with a Overweight recommendation. Analyst Price Forecast Suggests 1.32% Downside

Tue Dec 16, 2025

$100.00 | -2.60%

Momentum

Rating

FAQ About GH Stock Insights

What is GH current stock price?

What are GH stock strengths?

What is GH Risk Level?

What is GH market cap and volume?

What is GH current Stock IQ?

Should I buy GH stock right now?

Is GH a Strong Buy right now?

What does a 'Strong Buy' rating mean for GH?

What does a 'Strong Sell' rating mean for GH?

What factors influence GH's Stock IQ?

Explore our GH Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored GH Stock Strategies
Effective Risk Management

FIND US ON

Receive our GH Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

GH

Guardant Health

Current Price

$101.74

-$0.40 | -0.39%

52W High

$111.91

MKT CAP

$13.11B

52W Low

$31.75

VOL

$828.33K

P/E Ratio

N/A

AVG VOL

$2.09M

RSI

53.66

TREND

Uptrend

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

GH Rewards

Upgraded on attractively valued

GH Rewards

Earnings are forecast to grow

GH Rewards

Outperform the market

Linked to GH

Symbol

IQ

Close

Change

LH

2.54

251.43

+0.33%

EXAS

4.00

101.74

+0.18%

GH Price Performance

$108.52 (-6.25%)

$63.44 (+60.37%)

$54.8 (+85.66%)

$36.66 (+177.52%)

1year

6month

3month

1month

GH Analysts Opinion

GH Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

GH Analysts Opinion

GH Analysts opinion is positive and also has improved from the past 3 months

GH Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

81%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

43%

100%

GH Street Sentiment

GH Street Sentiment is extremely bullish and have positive views on the near-term outlook

GH Risk Level

GH has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Fair

LOW

HIGH

GH Performance Sentiment

Sentiments overview associated with GH events and the stock performance.

81%

19%

Positive

Negative

17 out of 21
events present

4 out of 21
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$102.14

Resistance
Price

$100.30

Current Price Range

$108.52

Show methods +

GH Stock IQ

Login to unlock Guardant Health (GH) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

GH Latest Analysis

Canaccord Names Guardant Health (GH) Top Life Science Pick Cites Strong Growth and Low Downside. Guardant Health Inc. (NASDAQ:GH) is one of the hottest large-cap stocks of 2025. On December 22 Canaccord raised the firms price target on Guardant Health to $125 from $100 with a Buy rating on the shares. The firm expects the life science sector to maintain its current upward trend well into 2026. Guardant Health remains [….]

Wed Dec 31, 2025

$102.14 | +1.53%

Momentum

Potential

Canaccord Genuity Maintains Guardant Health (GH) Buy Recommendation. Fintel reports that on December 22 2025 Canaccord Genuity maintained coverage of Guardant Health (NasdaqGS:GH) with a Buy recommendation. Analyst Price Forecast Suggests 7.76% Upside

Tue Dec 23, 2025

$102.50 | +1.14%

Rating

Mizuho Maintains Guardant Health (GH) Outperform Recommendation. Fintel reports that on December 17 2025 Mizuho maintained coverage of Guardant Health (NasdaqGS:GH) with a Outperform recommendation. Analyst Price Forecast Suggests 3.51% Upside

Thu Dec 18, 2025

$97.10 | -0.38%

Potential

Rating

Leerink Partners Maintains Guardant Health (GH) Outperform Recommendation. Fintel reports that on December 15 2025 Leerink Partners maintained coverage of Guardant Health (NasdaqGS:GH) with a Outperform recommendation. Analyst Price Forecast Suggests 1.90% Downside

Tue Dec 16, 2025

$100.00 | -2.60%

Momentum

Potential

Rating

Barclays Maintains Guardant Health (GH) Overweight Recommendation. Fintel reports that on December 15 2025 Barclays maintained coverage of Guardant Health (NasdaqGS:GH) with a Overweight recommendation. Analyst Price Forecast Suggests 1.90% Downside

Tue Dec 16, 2025

$100.00 | -2.60%

Momentum

Rating

JP Morgan Maintains Guardant Health (GH) Overweight Recommendation. Fintel reports that on December 15 2025 JP Morgan maintained coverage of Guardant Health (NasdaqGS:GH) with a Overweight recommendation. Analyst Price Forecast Suggests 1.32% Downside

Tue Dec 16, 2025

$100.00 | -2.60%

Momentum

Rating

Discover GH Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of GH. We're here to help you make informed investment decisions today.

FIND US ON

Receive our GH Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

GH Stock trends

GH Stock performance

GH Stock analysis

GH investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing GH

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing GH

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

GH Stock Analysis & IQ Rating | Guardant Health

BQ Stock IQ

GH Target Price

GH Risk Level

GH Analysts Opinion

GH Street Sentiment

GH Performance Sentiment

Technical Price Levels

Explore our GH Stock insights

Receive our GH Daily Alerts

GH Street Sentiment

GH Risk Level

Technical Price Levels

Discover GH Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of GH. We're here to help you make informed investment decisions today.

Receive our GH Daily Alerts

GH Alerts